HK Stock MarketDetailed Quotes

02192 MEDLIVE

Watchlist

9.500 -0.280-2.86%

Market Closed 12/01 16:08 CST

9.900High9.200Low1.20MVolume

MEDLIVE Key Stats

Cash Flow

All

YOY

Hide blank lines

(Q6)2023/06/30

(FY)2022/12/31

(Q6)2022/06/30

(FY)2021/12/31

(Q6)2021/06/30

(FY)2020/12/31

(Q6)2020/06/30

(FY)2019/12/31

(FY)2018/12/31

Turnover

31.49%173.51M

10.41%314.05M

0.99%131.95M

33.21%284.44M

47.11%130.66M

75.64%213.53M

--88.82M

45.66%121.57M

--83.46M

Operating income

31.49%173.51M

10.41%314.05M

0.99%131.95M

33.21%284.44M

47.11%130.66M

75.64%213.53M

88.82M

45.66%121.57M

83.46M

Cost of sales

-67.73%-68.28M

-21.03%-101.31M

-12.60%-40.71M

-46.10%-83.71M

-48.00%-36.16M

-29.10%-57.29M

---24.43M

-32.19%-44.38M

---33.57M

Operating expenses

-67.73%-68.28M

-21.03%-101.31M

-12.60%-40.71M

-46.10%-83.71M

-48.00%-36.16M

-29.10%-57.29M

-24.43M

-32.19%-44.38M

-33.57M

Gross profit

15.32%105.22M

5.98%212.74M

-3.45%91.24M

28.48%200.73M

46.77%94.51M

102.40%156.24M

64.39M

54.72%77.19M

49.89M

Selling expenses

0.71%-16M

-11.85%-28.9M

-6.16%-16.12M

-28.95%-25.84M

-86.72%-15.18M

-133.31%-20.04M

---8.13M

-21.30%-8.59M

---7.08M

Administrative expenses

-12.61%-57.42M

-20.24%-122.44M

-14.85%-50.99M

-211.98%-101.83M

-200.86%-44.4M

-3.98%-32.64M

---14.76M

-19.02%-31.39M

---26.38M

Operating interest expense

30.85%-195K

0.75%-531K

---282K

-155.98%-535K

----

---209K

----

Special items of operating profit

608.18%71.05M

2,950.00%74.16M

465.56%10.03M

-273.70%-2.6M

702.71%1.77M

1,704.82%1.5M

--221K

245.83%83K

--24K

Operating profit

202.91%102.66M

93.09%135.03M

-7.66%33.89M

-33.30%69.93M

-12.03%36.7M

181.14%104.85M

41.73M

126.59%37.29M

16.46M

Financing cost

----

-117.92%-231K

----

---106K

32.57%-296K

---439K

Share of profits of associates

--3K

700.00%12K

----

---2K

----

Earning before tax

202.92%102.66M

93.11%135.04M

-7.08%33.89M

-33.31%69.93M

-12.36%36.47M

183.39%104.85M

41.62M

130.95%37M

16.02M

Tax

83.87%-1M

65.09%-8.62M

63.00%-6.23M

-25.60%-24.68M

-136.91%-16.83M

-243.07%-19.65M

---7.1M

-212.83%-5.73M

---1.83M

After-tax profit from continuing operations

267.46%101.66M

179.41%126.42M

40.82%27.67M

-46.89%45.25M

-43.08%19.65M

172.46%85.2M

34.52M

120.38%31.27M

14.19M

Earning after tax

267.46%101.66M

179.41%126.42M

40.82%27.67M

-46.89%45.25M

-43.08%19.65M

172.46%85.2M

34.52M

120.38%31.27M

14.19M

Minority profit

325.00%2.94M

96.59%9.1M

--692K

--4.63M

----

Profit attributable to shareholders

265.99%98.72M

188.85%117.32M

37.30%26.97M

-52.33%40.62M

-43.08%19.65M

172.46%85.2M

34.52M

120.38%31.27M

14.19M

Basic earnings per share

263.76%0.1375

149.17%0.1642

3.00%0.0378

-58.61%0.0659

-43.10%0.0367

172.60%0.1592

0.0645

120.38%0.0584

0.0265

Diluted earnings per share

266.85%0.1339

149.30%0.1593

1.96%0.0365

-59.86%0.0639

-44.50%0.0358

172.60%0.1592

0.0645

120.38%0.0584

0.0265

Currency Unit

CNY

Accounting Standards

HKAS

Audit Opinions

Unqualified Opinion

Auditor

Ernst & Young

	(Q6)2023/06/30	(FY)2022/12/31	(Q6)2022/06/30	(FY)2021/12/31	(Q6)2021/06/30	(FY)2020/12/31	(Q6)2020/06/30	(FY)2019/12/31	(FY)2018/12/31
Turnover	31.49%173.51M	10.41%314.05M	0.99%131.95M	33.21%284.44M	47.11%130.66M	75.64%213.53M	--88.82M	45.66%121.57M	--83.46M
Operating income	31.49%173.51M	10.41%314.05M	0.99%131.95M	33.21%284.44M	47.11%130.66M	75.64%213.53M	88.82M	45.66%121.57M	83.46M
Cost of sales	-67.73%-68.28M	-21.03%-101.31M	-12.60%-40.71M	-46.10%-83.71M	-48.00%-36.16M	-29.10%-57.29M	---24.43M	-32.19%-44.38M	---33.57M
Operating expenses	-67.73%-68.28M	-21.03%-101.31M	-12.60%-40.71M	-46.10%-83.71M	-48.00%-36.16M	-29.10%-57.29M	-24.43M	-32.19%-44.38M	-33.57M
Gross profit	15.32%105.22M	5.98%212.74M	-3.45%91.24M	28.48%200.73M	46.77%94.51M	102.40%156.24M	64.39M	54.72%77.19M	49.89M
Selling expenses	0.71%-16M	-11.85%-28.9M	-6.16%-16.12M	-28.95%-25.84M	-86.72%-15.18M	-133.31%-20.04M	---8.13M	-21.30%-8.59M	---7.08M
Administrative expenses	-12.61%-57.42M	-20.24%-122.44M	-14.85%-50.99M	-211.98%-101.83M	-200.86%-44.4M	-3.98%-32.64M	---14.76M	-19.02%-31.39M	---26.38M
Operating interest expense	30.85%-195K	0.75%-531K	---282K	-155.98%-535K	----	---209K	----	----	----
Special items of operating profit	608.18%71.05M	2,950.00%74.16M	465.56%10.03M	-273.70%-2.6M	702.71%1.77M	1,704.82%1.5M	--221K	245.83%83K	--24K
Operating profit	202.91%102.66M	93.09%135.03M	-7.66%33.89M	-33.30%69.93M	-12.03%36.7M	181.14%104.85M	41.73M	126.59%37.29M	16.46M
Financing cost	----	----	----	----	-117.92%-231K	----	---106K	32.57%-296K	---439K
Share of profits of associates	--3K	700.00%12K	----	---2K	----	----	----	----	----
Earning before tax	202.92%102.66M	93.11%135.04M	-7.08%33.89M	-33.31%69.93M	-12.36%36.47M	183.39%104.85M	41.62M	130.95%37M	16.02M
Tax	83.87%-1M	65.09%-8.62M	63.00%-6.23M	-25.60%-24.68M	-136.91%-16.83M	-243.07%-19.65M	---7.1M	-212.83%-5.73M	---1.83M
After-tax profit from continuing operations	267.46%101.66M	179.41%126.42M	40.82%27.67M	-46.89%45.25M	-43.08%19.65M	172.46%85.2M	34.52M	120.38%31.27M	14.19M
Earning after tax	267.46%101.66M	179.41%126.42M	40.82%27.67M	-46.89%45.25M	-43.08%19.65M	172.46%85.2M	34.52M	120.38%31.27M	14.19M
Minority profit	325.00%2.94M	96.59%9.1M	--692K	--4.63M	----	----	----	----	----
Profit attributable to shareholders	265.99%98.72M	188.85%117.32M	37.30%26.97M	-52.33%40.62M	-43.08%19.65M	172.46%85.2M	34.52M	120.38%31.27M	14.19M
Basic earnings per share	263.76%0.1375	149.17%0.1642	3.00%0.0378	-58.61%0.0659	-43.10%0.0367	172.60%0.1592	0.0645	120.38%0.0584	0.0265
Diluted earnings per share	266.85%0.1339	149.30%0.1593	1.96%0.0365	-59.86%0.0639	-44.50%0.0358	172.60%0.1592	0.0645	120.38%0.0584	0.0265
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS
Audit Opinions	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	Unqualified Opinion
Auditor	--	Ernst & Young	--	Ernst & Young	--	Ernst & Young	--	Ernst & Young	Ernst & Young

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Paper Trade Start

Symbol

Direction

Buy

Sell

Types

LMT Order

Price

QTY

Amount

Buy

Claim up to $1 million virtual fund, join moomoo paper trading today! Claim Now >

02192 MEDLIVE

MEDLIVE Key Stats

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow